European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim a. Rhein, Germany

Watch
Boehringer Ingelheim Pharma GmbH & Co. KG

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

Boehringer Ingelheim Pharma GmbH & Co. KG

Identification

Ut
District Court of Mainz HRA 22206
Sirul
Siren 880616594
Siret
Siret 88061659400011
Lei
5299001JXIQ2V7N0ZD85
EUID
DET2304V.HRA22206

Address

Binger Str. 173, 55218 Ingelheim a. Rhein, Germany

Corporate purpose

Manufacturing of basic pharmaceutical products

History

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
56Authorized signatory (ppa)
1General partner
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

JOBS AT NORTH DATA

  • Modern Java Developer
Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
One known shareholder
Portfolio and Investments
2 known active shareholdings
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

2 Oct 2026
Patent: Packaging tightness
6 Jul 2026 in Hor
EU funding: Doctoral network on discovering pathomechanisms and novel drug optimization for AMD
14 Jun 2026
Patent: Method for optimizing chromatographic purification processes for biomolecules
28 May 2026
Authorized signatory (ppa): Cornelia Shah · No longer Authorized signatory (ppa) (5)
Year 2026 in Dpmam
4 trademark filings: BISOLVOMYCIN, Europharma, TIOSPIR, TIOVENT
1 Apr 2026 in Fk
Public funding (€365,492): ETOS: Electrochemical Cofactor Regeneration for Industrial Biocatalysis (BECBI) - B
1 Apr 2026 in Fk
Public funding (€298,339): ETOS: Electrosynthesis of five-ring-N-heterocycles in scalable flow electrolyzers (ESYN4HET) - B
20 Feb 2026 via C.H. Boehringer Sohn AG & Co. KG also 02/05/2025, 02/10/2024, 08/04/2024, 21/12/2022, 22/12/2021, 15/12/2020, 08/01/2020, 13/12/2018, 03/01/2018, 12/01/2017, 25/02/2016, 17/04/2015, 14/05/2014, 14/02/2013, 16/12/2011, 21/12/2010, 22/12/2009, 11/12/2008, 19/02/2008
Shareholder: C.H. Boehringer Sohn AG & Co. KG
31 Jan 2026
Patent: Atomizer
9 Jan 2026
Wordmark: “MOBIC“
6 Jan 2026
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (7)
3 Dec 2025
Patent: Nintedanib for use in the treatment of systemic scleroderma
15 Nov 2025
Patent: Needle for punching powder capsules for inhalation
Year 2025 in Dpmam
5 trademark filings: GASTROZEPINA, MONZAL …
27 Jun 2025 via Chrometra Scientific B.V.
EU funding (€290,272): Doctoral Network on Interfacial Water in Membrane Transport
12 Jun 2025
Authorized signatory (ppa) (7) · No longer Authorized signatory (ppa) (7)
30 Apr 2025
Patent: Atomizer
28 Feb 2025
Wordmark: “ADUMBRAN“
7 Jan 2025
Authorized signatory (ppa): Traugott L. Gruppe, Jörg S. Schnitzler · No longer Authorized signatory (ppa): Torsten Mau
1 Jan 2025 in Fk
Public funding (€120,025): QSens: Hyperpolarized and Scalable Nuclear Magnetic Resonance Spectroscopy for Pharmaceutical Research (QMED2-PHIP-NMR) - D
24 Dec 2024 in Hor
EU funding: Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments
1 Oct 2024 in Hor
EU funding: Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models
7 Sept 2024
Wordmark: “RUYEL“
3 Sept 2024
Authorized signatory (ppa) (5) · No longer Authorized signatory (ppa) (3)
1 Sept 2024 in Fk
Public funding (€177,252): Digital Ecosystem for AI-based Robotics (RoX) - Subproject: Further Development of a Logistics Robot for Individual Transport Processes in the Production and Logistics …
7 Aug 2024 in Hor
EU funding: Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
1 Aug 2024
Authorized signatory (ppa): Paola Casarosa, Christoph Ruland · No longer Authorized signatory (ppa) (4)
28 Jun 2024
Patent: Inhalator und Sieb für einen Inhalator
3 May 2024
Wordmark: “LATONID“
19 Feb 2024
Authorized signatory (ppa): Sandrine Bianchi, Lisa Matzen · No longer Authorized signatory (ppa) (2)
29 Nov 2023
Patent: Cleaning device, filter system and system
1 Oct 2023 in Fk
Public funding (€24,625): SynErgie3: Synchronized and energy-adaptive production technology for the flexible alignment of industrial processes to a fluctuating energy supply …
16 Aug 2023 as Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173
28 Jun 2023
Wordmark: “MEXITIL“
28 Jun 2023
Wordmark: “OPEN UP AND BREATHE“
20 Jun 2023
Word figurative mark: “resist“
1 Apr 2023 in Fk
Public funding (€223,598): ETOS: Electrochemical Hofmann degradation of carboxylic acid amides (HAVANA) - B
30 Mar 2023
Authorized signatory (ppa): Jochen Gann, Oliver Lutze · No longer Authorized signatory (ppa) (5)
19 Jan 2023 as Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173
Year 2022 in Euipotm
11 wordmarks: ASASANTIN, BolusacPlus, DIXARIT, From Mind to Market, OXIVENT, SPIRITIDE, SPIRIVACTIONS, SPIRIVENT, SPIROPENT, TIO, TIOVENT
11 Nov 2022
Wordmark: “CASPON“
26 Oct 2022
Authorized signatory (ppa): Jürgen Martin Seitz · No longer Authorized signatory (ppa) (3)
27 Jul 2022
Patent: Uses of DPP IV inhibitors
7 Jul 2022
Wordmark: “JOSIR“
30 Jun 2022
Authorized signatory (ppa): Jan Faßbender, Wolfram Lindner · No longer Authorized signatory (ppa) (1)
14 Apr 2022 via Boehringer Ingelheim Corporate Center GmbH also 20/01/2021, 28/01/2019, 13/02/2018
Shareholder: Boehringer Ingelheim Corporate Center GmbH
24 Jan 2022
Authorized signatory (ppa) (3)
1 Jan 2022 in Fk
Public funding (€90.00): QSens: Quantum Sensors for Biomedical Diagnostics (QMED) - C
Year 2021 in Euipotm
12 trademark filings (11 wordmarks, 1 figurative mark): BENVIS, CERELOG, CERESTAT, CoMicardis, FAVINT, LANCA, LEUTROL, MELBENO, MERADIV, PAROCIN, RENDIX …
19 Oct 2021
Figurative mark: “Figurative“
13 Oct 2021
Patent: Stable powder formulation containing an anticholinergic
20 Jul 2021
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (5)
19 May 2021
Patent: Anthelmintic heterocyclic compounds
7 Apr 2021
Patent: Cleaning process and control device
10 Nov 2020
No longer Authorized signatory (ppa) (35)
4 Aug 2020
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (5)
15 Jul 2020
Patent: Shearing Stress Application
15 Apr 2020
Patent: Propellant-free aerosol formulation for inhalation
13 Feb 2020 via Boehringer Ingelheim microParts GmbH also 13/02/2019, 10/04/2014, 05/12/2012, 05/12/2011, 25/06/2010
Shareholding: Boehringer Ingelheim microParts GmbH
8 Jan 2020
Other mark: “3-D“
7 Jan 2020
Wordmark: “Masigel“
12 Dec 2019
Authorized signatory (ppa) (5) · No longer Authorized signatory (ppa) (12)
Year 2019 in Epobase
6 European patent filings: Atomizer in the Form of an Inhaler for Medical Aerosol Therapy …
1 Dec 2019 in France
Address · Legal form: Société étrangère non immatriculée au RCS · Name: BOEHRINGER INGELHEIM PHARMA GMBH & CO KG · Segment clas­si­fi­ca­tion
Year 2019 in Dpmam
23 trademark filings: ALEUDRINA, Gastrozepin, Itrop, LOXOLA, MIDOTENS, Melbeno, Paracefan, Partusisten, SPIROPENT, Thomaeamin, Thomaegelin, Thomaejonin, Thomaelipid, Thomaemannit …
28 Aug 2019 in Hor
EU funding (€252,788): INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.
15 Aug 2019
Wordmark: “ECTRIS“
13 Aug 2019 in Hor
EU funding (€252,788): Proton transport and proton-coupled transport
31 Jul 2019
Other mark
18 Jun 2019
Patent: Inhalationsset mit Inhalierbarem Tiotropium-Pulver
1 May 2019 in Hor
EU funding: ENdoThelial macRophage Alliance In Neuroinflammation
18 Apr 2019
No longer Authorized signatory (ppa) (5) · Authorized signatory (ppa) (1)
25 Feb 2019
Authorized signatory (ppa) (7) · No longer Authorized signatory (ppa) (20)
Year 2018 in Dpmam
1 word figurative mark: AGEVIS, BIXONT, Dantreal, ECTRIS, IMUKIN, KELCINT, LANCA, LIBAVIE, MIMEC, PRETAG, QUENIA, REBRANQ, RELKIRBO, ROANA, SMI …
30 Nov 2018
Utility patent: Faltschachtel
17 Nov 2018
Patent: Verfahren und Vorrichtung zur Rückgewinnung von niedrig siedenden Halogenalkanen aus Abgasen
19 Oct 2018
Wordmark: “BIXONT“
19 Oct 2018
Wordmark: “BONESC“
18 Oct 2018
Patent: Medikamente für Inhalationen Enthaltend ein Anticholinergikum und ein Betamimetikum
Year 2018 in Epobase
5 European patent filings: Mouthpiece for an Inhaler …
17 Apr 2018
No longer Authorized signatory (ppa) (7) · Authorized signatory (ppa) (1)
1 Mar 2018 in Fk
Public funding (€206,618): Strategic Alliance Knowledge-Based Process Intelligence - New Paths to Stable Bioprocesses, TP P, Phase 2
Year 2017 in Dpmam
176 trademark filings: ADOLES, BENALC, BISOLBRONC, BISOLVON, BISOLVON BALMIA, BISOLVON CLARA, BISOLVON FRES, BISOLVON ISAMOS, BISOLVON KWIK, BISOLVON MELIA, BISOLVON NARIS, BISOLVON NATURALIGN …
13 Dec 2017
Authorized signatory (ppa) (14) · No longer Authorized signatory (ppa) (33)
Year 2017 in Euipotm
5 wordmarks: ATRONASAL, ATRONASE, BANTIXAL, SAMEXOL, SAVONEX
Year 2017 in Epobase
6 European patent filings: Hydrochlorides of 1-[(3-Cyano-Pyridin-2-YL) Methyl]-3-Methyl-7-(2-Butin-1-YL)-8-[3-Amino-Piperidin-1-YL]-Xanthin, Their Manufacture and USE of Same AS Medicine …
20 Feb 2017 via Boehringer Ingelheim Corporate Center GmbH also 20/02/2017, 30/12/2011
Shareholder: Dr. Karl Thomae GmbH
30 Dec 2016
Word figurative mark: “Boehringer Ingelheim“
Year 2016 in Dpmam
18 trademark filings (2 wordmarks, 2 word figurative marks, 1 other mark): ACARDI, CONCERT, DAGANTAC, FRUBIAVIT, LACORA, MELBENO, MICARIS, PEDOPUR, PERSUMBRAN, Pres, STACORA, Sekretovit, TIOTIDE …
8 Dec 2016
Authorized signatory (ppa) (12) · No longer Authorized signatory (ppa) (13)
2 Dec 2016 via C.H. Boehringer Sohn Selbstmedikation GmbH & Co. KG
General partner: C.H. Boehringer Sohn Selbstmedikation GmbH & Co. KG
21 Nov 2016
LP: der Kommanditistin Dr. Karl Thomae, Gesellschaft mit beschränkter Haftung von Biberach an der Riß nach Ingelheim am Rhein und Übertragung der Kommanditeinlage der Kommanditistin C.H … …
Year 2016 in Epobase
5 European patent filings: Novel Medicaments for Inhalation …
5 Nov 2016
Patent: Method for ventilation of objects and device for ventilation of objects, in particular ventilation system
1 Jun 2016 in Fk
Public funding (€132,197): DipImpact - Uncovering the Functions and Mechanisms of Medium Additives such as Dipeptides to Improve Productivity and Titers in Cell Culture Approaches, Subproject BI
1 May 2016
Wordmark: “BUSCODOL“
16 Mar 2016
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (1)
12 Mar 2016 as Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173
7 Feb 2016
Word figurative mark: “Dulcolax“
4 Feb 2016
Patent: Verfahren zur Belüftung von Objekten und Vorrichtung zur Belüftung von Objekten, insbesondere raumlufttechnische Anlage
Year 2015 in Dpmam
14 trademark filings: Biolavan, CAMERA MEDICA, GLUMETANORM, IMUFOR, JETARO, MAPELOR, RALUZZO, RESPIMAX, Tranquo-Buscopan …
18 Nov 2015
Authorized signatory (ppa) (14) · No longer Authorized signatory (ppa) (11)
15 Oct 2015 via Dr.Karl Thomae GmbH also 23/03/2015, 24/01/2011
Shareholder: Dr.Karl Thomae GmbH
1 Oct 2015
Patent: Verfahren zur Herstellung von 3-Hydroxy-geschützter Betulinsäure
Year 2015 in Epobase
5 European patent filings: Bicyclic Heterocycles, Medicaments Containing These Compounds, Their use and Methods for the Production Thereof …
11 Aug 2015 via Chemotargets SL
EU funding (€463,820): Big Data in Chemistry
Year 2015 in Euipotm
7 trademark filings (6 wordmarks, 1 figurative mark): JETARO, ORIVOCA, ORLEXUS, PREPEGION, QUENIA, ROANA …
16 Jan 2015
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (8)
1 Jan 2015 in Hor
EU funding: Enhancing CHO by Mammalian Systems Biotechnology (eCHO systems)
1 Jan 2015
Patent: Tempern
Year 2014 in Dpmam
1 wordmark: ALUPENT, BEROTEC, BOEHRINGER, DITEC, FAVYND INPRESGO, FIROL, Florisan, MAQUIL, ORIVOCA, ORVINIUM, PRATUS, PREPEGION, PULTEC, SEMEOS, VIORIST …
Year 2014 in Epobase
12 European patent filings: Use of Nintedanib for the Treatment of Lung Fibrosis …
18 Nov 2014
Authorized signatory (ppa) (20) · No longer Authorized signatory (ppa) (5)
Year 2014 in Dpmap
10 patent filings: 8- [3-amino-piperidine-1-yl] -xanthines, their preparation and use as a medicament …
Year 2014 in Euipotm
8 wordmarks: ALDRIUM, ATAMARIS, INHALETTEN, NIMARIV, SICRAMON, TALIANTA, TIRENIS, VENTOX
13 Mar 2014
No longer Authorized signatory (ppa) (3) · Authorized signatory (ppa) (2)
13 Mar 2014
Authorized signatory (ppa) (13) · No longer Authorized signatory (ppa) (7) · Address
21 Feb 2014
Authorized signatory (ppa) (13) · No longer Authorized signatory (ppa) (7)
Year 2013 in Dpmam
31 trademark filings (1 wordmark, 1 figurative mark, 1 word figurative mark): ADUMBRAN, AGIDAR, ALDRIUM, ARINAVIS, ATAMARIS, ATROVENT, DEXA-Rhinospray, FAVYND, Ganzec, Ganzid, Ganzoc, Ganzol …
Year 2013 in Epobase
18 European patent filings: Bilayer Tablet Comprising Telmisartan and Amlodipine …
Year 2013 in Dpmap
5 patent filings: Needle for punching powder capsules for inhalation …
6 Oct 2013
Wordmark: “FLABOX“
7 Feb 2013
Authorized signatory (ppa) (14) · No longer Authorized signatory (ppa) (21)
Year 2012 in Epobase
27 European patent filings: Inhalation Powder Formulations Containing Enantiomerically Pure Beta-Agonists …
Year 2012 in Dpmam
33 trademark filings (5 wordmarks, 1 figurative mark, 2 word figurative marks): BESIR, BISOLVONAT, BOEHRINGER INGELHEIM BIOXCELLENCE, CIRIR, Denan mite, ELEXXOS, FINES, FIRMIN, FLABOX, GANOR, GARAS …
Year 2012 in Euipotm
10 wordmarks: ALESION, BINIAT, DITEC, ELEXXOS, LOXOLA, RHEXOS, TORDANO, XEVENIS, XYNDIOX, YAVEMO
20 Jun 2012
Authorized signatory (ppa) (19) · No longer Authorized signatory (ppa) (7)
Year 2011 in Dpmam
1 figurative mark: Aerovent, Aknell, Argferon, BENVIS, Convergal, Corimot, Daquiran, Geriox, Lactolin, Lindormin, MERADIV, Mapelor, Multiferon, Portarox, RESOMER …
23 Oct 2011
Wordmark: “VENZO“
Year 2011 in Epobase
11 European patent filings: Technical Synthesis Method for Producing Tiotropium Bromide …
3 Jun 2011
Authorized signatory (ppa) (28) · No longer Authorized signatory (ppa) (9)
5 May 2011
Patent: Salbenaufstreicher
2 May 2011
Patent: Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
23 Mar 2011
Patent: Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
Year 2010 in Epobase
14 European patent filings: Improved Method for the Production of Betulinic Acid …
Year 2010 in Dpmam
26 trademark filings (4 wordmarks, 1 figurative mark): AUXILOSON, Amylact, BI-PurEX, Beroset, Bisanex, CO-PRITOR, CONCERT, Ciko, DeltaAmin, FRACORA, Festinas, MICARDREX, MONDRA, Optipurgan, PRADOVIA …
Year 2010 in Euipotm
9 trademark filings (8 wordmarks, 1 figurative mark): BENALC, BIRIC, MONDRA, PRETAG, TEXEGA, TRONIAT, ZIOBREL, ZOLTRA …
21 Oct 2010
Patent: Ointment spreader
20 Oct 2010
Patent: Trockenpulverinhalator
27 Apr 2010
Authorized signatory (ppa) (8) · No longer Authorized signatory (ppa) (7)
Year 2009 in Epobase
26 European patent filings: 8-[3-Amino-Piperidin-1-YL]-Xanthines, the Production Thereof and the USE of the Same AS Medicaments …
Year 2009 in Euipotm
13 wordmarks: CLEDACTO, CORIMOT, ECORSAL, ELERA, GORBAL, KELCINT, LERXIN, MAZAXXI, MIMEC, MIZUN, PULVENT, TOMPALA, ZISCA
Year 2009 in Dpmam
44 trademark filings (6 wordmarks, 1 figurative mark): ALBRENO, ALEUDRINA, APRADAX, ARTEN, Acalon, Aminalon, BI-STAR, CERELOG, CLEDACTO, COMBIPRES, CONCERT, Cresima, ELERA, FRUBIIMMUN, GORBAL …
Year 2009 in Dpmap
10 patent filings: Pyrimidinderivate, Arzneimittel enthaltend diese Verbindungen, deren Verwendung und Verfahren zu ihrer Herstellung …
19 Jun 2009
Authorized signatory (ppa) (10) · No longer Authorized signatory (ppa) (7) · General partner: Boehringer Ingelheim Deutschland GmbH
28 May 2009
Authorized signatory (ppa) (10) · No longer Authorized signatory (ppa) (6) · General partner: Boehringer Ingelheim Deutschland GmbH · Limited Partner: C.H. Boehringer Sohn AG & Co. KG
1 Apr 2009 in Fk
Public funding (€66,849): Development of efficient methods for the detection and depletion of host-cell proteins from therapeutic antibodies, SP 1
1 Jan 2009 in Fk
Public funding (€107,473): Technical Protein Crystallization for Purification, Stabilization and Formulation of Pharmaceutically Active Proteins, SP 3
Year 2008 in Epobase
34 European patent filings: SM-Protein Based Secretion Engineering …
Year 2008 in Dpmam
49 trademark filings (3 wordmarks, 6 figurative marks, 2 word figurative marks): ALGARET, ATTEC, BALANO, BIANTRON, BINEB, BISOLPIRIN, CINI, COMTION, DANTREAL, EFFORTILOS, FRIPEIN, FRUBILURGYL …
Year 2008 in Dpmap
12 patent filings (2 patents, 1 utility patent): Folding carton …
Year 2008 in Euipotm
8 wordmarks: AEROVENT, BEROVENT, MIRAPEX, PalliaCare, PalliaMed, RESPIMAX, UDV, UDVs
15 Aug 2008
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (8)
22 Apr 2008
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (4)
Year 2007 in Dpmap
13 patent filings: Method for ventilation of objects and device for ventilation of objects, in particular ventilation system …
Year 2007 in Dpmam
90 trademark filings (18 wordmarks, 5 figurative marks, 3 word figurative marks, 3 other marks): ALENION, ALERAS, ALESION, ALESNION, ALVEOFACT, ASASANTINE, AXIRESS, Acalon, BEROCHEC, BEROCONTROL …
Year 2007 in Epobase
89 European patent filings: Method of Producing a Bilayer Pharmaceutical Tablet Comprising Telmisartan and Hydrochlorothiazide …
Year 2007 in Euipotm
6 wordmarks: BlueLine, HAECKOZAL, LOXITAN, RESPODIL, TOPCUTAN, XELIOC
14 Sept 2007
Authorized signatory (ppa) (1)
4 Sept 2007
Authorized signatory (ppa) (1)
27 Apr 2007
Authorized signatory (ppa) (13) · No longer Authorized signatory (ppa) (9)
16 Apr 2007
Authorized signatory (ppa) (13) · No longer Authorized signatory (ppa) (7)
Year 2006 in Epobase
63 European patent filings: Pharmaceutical Compositions of Anticholinergics and P38 Kinase Inhibitors in the Treatment of Respiratory Diseases …
Year 2006 in Dpmam
25 trademark filings (2 wordmarks, 5 figurative marks): ABRENO, AKNEL, BI-HEX, BISOLVON NAC, BOEROCEROL, Citca, DOSPIR, DOZPIR, ILAGUR, INGOMUN, LERC, PERISKOP, RESOMER, SENELL, TECTIL …
Year 2006 in Euipotm
4 wordmarks: DONAFOR, KINZALPLUS, MOVICOX, TOXKIN
Year 2006 in Dpmap
11 patent filings: Procedure for sterilizing a film container …
21 Jun 2006
Patent: Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors
24 Mar 2006
Authorized signatory (ppa) (6) · No longer Authorized signatory (ppa) (6)
25 Jan 2006
Authorized signatory (ppa) (1)
Year 2005 in Epobase
62 European patent filings: Method for Producing Optically Active Dihydropyrones …
20 Dec 2005
Reg­is­tra­tion · ppa (23) · GP: Boehringer Ingelheim Komplementär GmbH · LP: Dr. Karl Thomae GmbH, C. H. Boehringer Sohn · Seat: Ingelhelm am Rhein · Name: Boehringer Ingelheim Pharma GmbH & Co. KG
Year 2005 in Dpmam
50 trademark filings (5 wordmarks, 2 other marks): ARGFERON, Aerovent, BERONOR, BISOLVINIS, BISOLVONETTEN, BOE, BOEROCEROL, BRONCHO-BEROTEC, Boerozym, CONFERON, DELTA-BALANCE, DELTALIPID, DELTAVIT …
Year 2005 in Dpmap
6 patent filings: Dosing device and method for dosing …
Year 2005 in Euipotm
10 wordmarks: ARINAVIS, Boehringer, GASTROZEPIN, GLURENORM, ITROP, KINZALKOMB, KINZALMONO, LONARID, MICROPARTS, PRADAXA
1 Sept 2005 in Fk
Public funding (€600,929): Nano-Carriers with Temporal and Spatially Controlled Release of Active Substances for Inhalation (NanoInhale) - Subproject: Processing, Particle Formulation and …
There are no publications matching your search.

Mentions

26 Sept 2026 in Rne
Reg­is­tra­tion: 01/12/2019 · Segment clas­si­fi­ca­tion · Corporate Purpose
31 Jul 2026 in Ler
Direct parent
31 Jul 2026 in Ler
Ultimate parent
7 Jun 2024 in Hrdk also 24/01/2024, 15/01/2024, 27/10/2016, 15/09/2016, 29/09/2014, 15/06/2012, 14/06/2012, 09/01/2012, 08/10/2010, 30/09/2008, 08/10/2007, 08/10/2007
Internationale Schule Ulm/Neu-Ulm gGmbH: “Liste der Gesellschafter“
31 Jan 2020 in Hrdk also 13/12/2019
Boehringer Ingelheim microParts GmbH: “Liste der Gesellschafter“
Year 2017 in Hrdk
Shareholding
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.